Doxazosin: Effective Blood Pressure and BPH Management
| Product dosage: 1 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 120 | $0.39 | $46.24 (0%) | 🛒 Add to cart |
| 180 | $0.35 | $69.36 $62.32 (10%) | 🛒 Add to cart |
| 270 | $0.32 | $104.03 $86.44 (17%) | 🛒 Add to cart |
| 360 | $0.31
Best per pill | $138.71 $110.57 (20%) | 🛒 Add to cart |
| Product dosage: 2 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.25 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $73.88 $62.32 (16%) | 🛒 Add to cart |
| 120 | $0.63 | $98.51 $75.39 (23%) | 🛒 Add to cart |
| 180 | $0.57 | $147.76 $102.53 (31%) | 🛒 Add to cart |
| 270 | $0.52 | $221.64 $141.73 (36%) | 🛒 Add to cart |
| 360 | $0.51
Best per pill | $295.52 $181.93 (38%) | 🛒 Add to cart |
| Product dosage: 4 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.41 | $42.22 (0%) | 🛒 Add to cart |
| 60 | $1.14 | $84.43 $68.35 (19%) | 🛒 Add to cart |
| 90 | $1.06 | $126.65 $95.49 (25%) | 🛒 Add to cart |
| 120 | $1.01 | $168.87 $121.62 (28%) | 🛒 Add to cart |
| 180 | $0.97 | $253.30 $174.90 (31%) | 🛒 Add to cart |
| 270 | $0.94 | $379.95 $254.30 (33%) | 🛒 Add to cart |
| 360 | $0.93
Best per pill | $506.60 $333.71 (34%) | 🛒 Add to cart |
Synonyms | |||
Doxazosin is a selective alpha-1 adrenergic receptor antagonist belonging to the quinazoline class. It is primarily indicated for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents, and for the treatment of urinary outflow obstruction and associated symptoms in patients with benign prostatic hyperplasia (BPH). Its mechanism of action involves relaxation of vascular and prostatic smooth muscle, leading to decreased peripheral vascular resistance and improved urinary flow. This medication represents a well-established option in therapeutic regimens for these common conditions, supported by extensive clinical evidence and decades of real-world use.
Features
- Selective alpha-1 adrenergic receptor blockade
- Available in standard and extended-release (XL) tablet formulations
- Dosing flexibility with available strengths of 1 mg, 2 mg, 4 mg, and 8 mg
- Demonstrated efficacy in reducing both systolic and diastolic blood pressure
- Proven to improve urinary flow rates and reduce BPH symptom scores (e.g., IPSS)
- Convenient once-daily dosing regimen
Benefits
- Provides effective and sustained 24-hour blood pressure control with a single daily dose.
- Significantly improves lower urinary tract symptoms associated with BPH, enhancing quality of life.
- Offers a favorable metabolic profile; it does not adversely affect blood glucose or lipid levels.
- Can be used effectively in combination with other antihypertensive drug classes (e.g., diuretics, ACE inhibitors, calcium channel blockers).
- Reduces peripheral vascular resistance without causing significant reflex tachycardia in most patients.
- The extended-release formulation may further minimize the incidence of peak-dose side effects like dizziness.
Common use
Doxazosin is commonly prescribed for two primary indications. First, for the management of hypertension. It is effective as a first-line agent or, more commonly, as an add-on therapy in patients whose blood pressure is not adequately controlled by other medications. Second, it is used for the treatment of the signs and symptoms of benign prostatic hyperplasia. Patients experience relief from symptoms such as hesitancy, incomplete bladder emptying, urinary frequency, urgency, nocturia, and weak stream. It is important to note that while doxazosin improves urine flow and symptoms, it does not reduce the size of the prostate gland itself.
Dosage and direction
Hypertension:
- The initial dose is 1 mg administered once daily, preferably at bedtime to minimize the potential for first-dose syncope.
- The dosage may be slowly titrated upward based on individual patient response and tolerability. Dosage adjustments should typically occur at 1-2 week intervals.
- The usual therapeutic dosage range is 2-8 mg once daily. The maximum recommended dose is 16 mg per day, though doses above 4 mg provide only minimal additional blood pressure effect.
Benign Prostatic Hyperplasia:
- The initial dose is also 1 mg once daily at bedtime.
- The dose should be titrated to a recommended dose of 2-4 mg once daily, and up to 8 mg once daily if needed, based on symptomatic response and tolerability.
- Doxazosin XL (extended-release) tablets are initiated at 4 mg once daily with breakfast. This dosage should not be titrated for the first three to four weeks.
Administration:
- Standard tablets may be taken with or without food.
- XL tablets must be swallowed whole and must not be crushed, chewed, or divided. They must be taken with breakfast.
- Consistent timing of administration is important for maintaining stable drug levels.
Precautions
- First-Dose Effect: A marked decrease in blood pressure with syncope (fainting) can occur within 90 minutes of the initial dose or after a rapid dosage increase. This risk is mitigated by initiating therapy at the 1 mg dose and taking it at bedtime.
- Orthostatic Hypotension: Dizziness, lightheadedness, and palpitations can occur, especially when standing up quickly from a sitting or lying position. Patients should be cautioned to rise slowly.
- Cataract Surgery: A condition known as Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients on or previously treated with alpha-1 blockers like doxazosin. Ophthalmologists should be informed of the patient’s current or past use of this medication.
- Priapism: Rare cases of painful or prolonged erection (lasting more than 4 hours) have been reported. This is a medical emergency requiring immediate treatment to prevent permanent tissue damage.
- Use with caution in patients with severe hepatic impairment.
- Patients should avoid driving or operating heavy machinery until they know how doxazosin affects them, particularly during the initiation and titration phases.
Contraindications
Doxazosin is contraindicated in patients with:
- A known hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any component of the formulation.
- A history of orthostatic hypotension.
- Concurrent use with other potent alpha-1 adrenergic blocking agents is not recommended.
Possible side effect
Common side effects (≥2%) are generally related to its pharmacological action and are often dose-dependent and transient. They include:
- Dizziness (15.6%)
- Fatigue (8.2%)
- Headache (7.8%)
- Somnolence (drowsiness) (5.2%)
- Nausea (3.9%)
- Edema (peripheral edema) (3.1%)
- Rhinitis, nasal congestion (3.0%)
- Hypotension, postural hypotension (2.9%)
- Palpitations (2.5%)
Less common but serious side effects require medical attention:
- Syncope (fainting) (0.7%)
- Symptomatic orthostatic hypotension
- Priapism (rare)
- Signs of an allergic reaction (rash, hives, itching, swelling of the face/lips/tongue/throat)
Drug interaction
Doxazosin can interact with several other medications, potentially increasing the risk of hypotension:
- Other Antihypertensives: Concomitant use with other blood pressure-lowering drugs (diuretics, beta-blockers, ACE inhibitors, calcium channel blockers) may have an additive hypotensive effect. Careful monitoring is advised.
- Phosphodiesterase-5 Inhibitors (e.g., sildenafil, tadalafil): Concurrent use can potentiate the blood pressure-lowering effects of doxazosin, leading to significant hypotension and syncope. Concomitant use is not recommended.
- CYP3A4 Inhibitors: Strong inhibitors of the CYP3A4 enzyme system (e.g., ketoconazole, itraconazole, ritonavir) may increase doxazosin plasma concentrations, increasing the risk of adverse effects. Caution is warranted.
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs like ibuprofen or naproxen may reduce the antihypertensive effect of doxazosin by inhibiting prostaglandin synthesis and causing fluid retention.
Missed dose
- If a dose is missed, it should be taken as soon as remembered on the same day.
- If it is near the time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed.
- Do not take a double dose to make up for a missed one.
Overdose
- Manifestation: The primary expected manifestation of an overdose is severe hypotension, which may present as dizziness, lightheadedness, fainting, or tachycardia as a compensatory mechanism.
- Management: The patient should be placed in a supine position with their legs elevated. This alone may suffice to restore blood pressure. Supportive care, including IV fluids and vasopressor agents (e.g., norepinephrine), should be administered if necessary. Gastric lavage or activated charcoal may be considered if ingestion was very recent. Vital signs and renal function should be monitored closely.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F).
- Keep the medication in its original container, tightly closed, and protected from light and moisture.
- Keep out of reach of children and pets.
- Do not flush medications down the toilet or pour them down a drain. Dispose of unused medication via a official medicine take-back program or according to FDA guidelines.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the drug’s prescribing information but may not be all-inclusive.
Reviews
- “As a cardiologist with over 20 years of practice, doxazosin remains a valuable tool in my arsenal, particularly for hypertensive patients who also present with BPH. Its dual-action benefit is significant. The key is slow titration to mitigate the first-dose effect.” – Dr. A. Reynolds, MD
- “Prescribed for my BPH. Noticed a marked improvement in urinary flow within two weeks. The first few days I felt quite dizzy, but that subsided. It’s been effective for me for over a year now.” – Patient, 68
- “A well-tolerated add-on therapy for resistant hypertension. I find its neutral metabolic profile advantageous for my diabetic patients who need a third or fourth agent.” – Clinical Pharmacist Specialist
- “The dizziness was too pronounced for me, even after the initial titration period. My doctor switched me to an alternative medication.” – Patient, 54
- “From a pharmacological standpoint, its selectivity for alpha-1 receptors makes it a cleaner agent than its non-selective predecessors. Its role in modern therapy is well-defined, though it is often not a first-line monotherapy choice.” – Professor of Pharmacology